ArticleBritish journal of cancer2026
Diabetes mellitus and health-related quality of life in long-term survivors of breast, colorectal or prostate cancer: a population-based prospective study.
Article in British journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundWe examined the association between diabetes mellitus (DM) and health-related quality of life (HRQOL) in long-term cancer survivors (LTCS) 14-24 years post-diagnosis, and evaluated the role of DM in the HRQOL of cancer survivors and cancer-free controls.
methodsWe analysed 6811 LTCS diagnosed with breast, colorectal, or prostate cancer between 1994 and 2004, surveyed in 2008-2011 and 2018-2019, and 1701 controls surveyed in 2013-2014. Multiple linear regression and linear mixed regression models were used to assess cross-sectional and prospective associations of DM and cancer with HRQOL, between participants with and without cancer, and between diabetics and non-diabetics.
resultsAt baseline, DM prevalence was 14%, and mean age of LTCS with DM was 72 years. LTCS with DM reported consistently poorer HRQOL than non-diabetic counterparts at baseline, with some HRQOL dimensions showing stronger associations with DM than with cancer in cross-sectional analysis. Although cancer generally showed a stronger association with poorer HRQOL than DM, DM was more strongly associated with worse physical functioning, global health status, pain, and appetite loss. The longitudinal perspective revealed similar associations between DM and HRQOL as the cross-sectional perspective for all scales.
conclusionThe findings highlight the need for comprehensive care strategies that address both cancer and DM to enhance health outcomes in diabetic LTCS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.